Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...

On Thursday, Tilray Medical, a division of medical marijuana giant Tilray Brands, Inc. (NASDAQ:TLRY), announced the final ...

Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth ...

Tilray and Anheuser-Busch reached an all-cash deal for the former to take ownership of a handful of popular brands. The cannabis company announced the move on Monday. The legalization of marijuana ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

Tilray Brands, Inc. (NASDAQ:TLRY) Q1 2025 Earnings Call Transcript October 10, 2024 Tilray Brands, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.05. Operator ...

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, ...

Brands announces the launch of “Men’s Health on Tap,” a new podcast series hosted by distinguished doctors, Dr.

Thank you for joining today's conference call to discuss Tilray Brands' Financial Results for the First Quarter ended August 31, 2024. All lines have been placed on mute to prevent any background ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tilray Brands, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.05. Operator: Thank you for joining today’s conference call to discuss Tilray Brands’ Financial ...